SCHEMBL21246447

SCHEMBL21246447

COC(=O)c1cn2cc(C)ccc2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.52
KDM4E B2RXH2 7/20 0.52
SMN1; SMN2 Q16637 6/20 0.52
ALDH1A1 P00352 6/20 0.52
POLB P06746 1/20 0.51
MAPT P10636 2/20 0.48
NPC1 O15118 5/20 0.47
HPGD P15428 2/20 0.47
EGLN1 Q9GZT9 2/20 0.47
LMNA P02545 1/20 0.47
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
MITF O75030 1/20 0.45
KDM5A P29375 1/20 0.45
KDM5C P41229 1/20 0.45
PAX8 Q06710 1/20 0.45
MAP3K5 Q99683 1/20 0.45
METTL3 Q86U44 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL871014 0.85 KDM4E (0.69) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL1553322 0.84 PIK3CG (0.47) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL22479152 0.84 KDM4E (0.46) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL16396042 0.84 RAB9A (0.48) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL2638074 0.81 PTGS1 (0.59) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL16376280 0.81 RAB9A (0.50) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL8065354 0.79 TGFBR1 (0.50) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL21001635 0.79 ALDH1A1 (0.52) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL16402038 0.79 ALDH1A1 (0.45) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB
SCHEMBL1583201 0.79 PTGS1 (0.66) RAB9AKDM4ESMN1; SMN2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3746451-B1 BENZYL-, (PYRIDIN-3-YL)METHYL- OR (PYRIDIN-4-YL)METHYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2023-07-12 EP disclosed
US-11254688-B2 Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-02-22 US disclosed
US-20210053985-A1 BENZYL-, (PYRIDIN-3-YL)METHYL -OR (PYRIDIN-4-YL)-METHYL-SUBSTIITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-02-25 US disclosed
WO-2019149657-A1 BENZYL-, (PYRIDIN-3-YL)METHYL- OR (PYRIDIN-4-YL)METHYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-08-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210053985-A1 BENZYL-, (PYRIDIN-3-YL)METHYL -OR (PYRIDIN-4-YL)-METHYL-SUBSTIITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS MBOAT4, GIPR, ADIPOR1 RAB9A 3658/4885KDM4E 466/4885SMN1; SMN2 3934/4885
US-11254688-B2 Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors MBOAT4, ADIPOR1, GIPR RAB9A 3197/4885KDM4E 376/4885SMN1; SMN2 3837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.